Page last updated: 2024-11-07

quinoprazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

quinoprazine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159481
CHEMBL ID494487
SCHEMBL ID12851549
MeSH IDM0205230

Synonyms (24)

Synonym
HMS1473C09
benzo(g)quinolin-4-amine, n-(4-(4-ethyl-1-piperazinyl)phenyl)-
n-(4-(4-ethyl-1-piperazinyl)phenyl)benzo(g)quinolin-4-amine
quinoprazine
CBDIVE_004992
OPREA1_224629
CHEMDIV3_000053
EU-0000010
IDI1_019371
NCGC00173873-01
AKOS001483131
115618-99-0
CHEMBL494487
n-[4-(4-ethylpiperazin-1-yl)phenyl]benzo[g]quinolin-4-amine
STK525165
4-(4-(4-ethylpiperazinyl-1)phenylamino)benzo(g)quinoline
us9211296, table 7, compd: 1
bdbm196131
SCHEMBL12851549
DTXSID10921777
n-[4-(4-ethylpiperazin-1-yl)phenyl]benzo[g]quinolin-4(1h)-imine
n-(4-(4-ethylpiperazin-1-yl)phenyl)benzo[g]quinolin-4-amine
HY-147371
CS-0567634
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1057860Cytotoxicity against mouse dividing ScN2a-cl3 cells assessed as cell viability at 10 uM after 5 days by calcein-AM staining-based fluorescence assay2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.
AID390739Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as protection from virus-induced lysis of cell monolayer up to 200 uM after 20 hrs2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID1057859Inhibition of RML prion protein infected in mouse stationary-phase ScN2a-cl3 cells expressing full length mouse PrP assessed as reduction of PrPsc level at 10 uM after 5 days by ELISA2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.
AID1057865Inhibition of RML prion protein infected in mouse dividing ScN2a-cl3 cells expressing full length mouse PrP assessed as reduction of PrPsc level at 10 uM after 5 days by ELISA2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.
AID390738Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as reduction in plaque formation up to 200 uM after 20 hrs2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID1057858Cytotoxicity against mouse stationary-phase ScN2a-cl3 cells assessed as cell viability at 10 uM after 5 days by calcein-AM staining-based fluorescence assay2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.
AID390731Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
AID390740Cytotoxicity against african green monkey BSC1 cells up to 200 uM after 20 to 120 hrs WST-1 based assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]